Project Grant R01HL175579
Award Date
8/15/24
Completion Date
6/30/29
Dollars Obligated
$740K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43201, USA
Similar Awards
This federal Project Grant award of $332,862.00 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, will support research to assess night-to-night variability in novel sleep disordered breathing severity metrics and their impact on daytime functioning. The study aims to characterize reliable biomarkers of obstructive sleep apnea (OSA) severity, as the current standard measure (Apnea-Hypopnea Index) underestimates...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,415,112 project grant under the Cardiovascular Diseases Research (CFDA 93.837) program to the Board of Regents of the University of Nebraska, University of Nebraska Medical Center (UNMC) Division. The grant, awarded on September 17, 2024, aims to evaluate a telehealth-delivered adaptive intervention to promote continuous positive airway pressure (CPAP) therapy adherence and improve health outcomes for adults newly diagnosed...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), part of the Cardiovascular Diseases Research program (CFDA 93.837), provides $711,226 to the University of California, Los Angeles (UCLA) to conduct research on the impacts of obstructive sleep apnea (OSA) on the brain. The objectives are to: 1) examine regional brain temperatures in OSA patients compared to controls; 2) assess whole-brain metabolite and antioxidant levels in OSA and controls; 3)...
This $128,047 federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports the development of an innovative urine-based diagnostic test for obstructive sleep apnea (OSA). The grant recipient, PGXL Technologies LLC, is a minority-owned for-profit company collaborating with the University of Louisville Research Foundation to create a non-invasive urine assay that can detect OSA through a panel of...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $162,728 to the University of California, San Diego (UCSD) to conduct research on the cardiovascular impacts of comorbid obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), known as overlap syndrome (OVS). The central hypothesis is that poor outcomes in OVS are driven by more pronounced right and left heart...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,474,280 Project Grant (CFDA 93.837 Cardiovascular Diseases Research) to Case Western Reserve University to conduct a randomized controlled trial studying the impact of a couple-oriented behavioral therapy intervention on continuous positive airway pressure (CPAP) adherence among 220 African American patients with obstructive sleep apnea and their bed partners. The project aims to improve patient and partner sleep and well-being...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $115,125 to the University of Miami to investigate the impact of obstructive sleep apnea (OSA) and HIV on ventricular repolarization lability. The 2-year study aims to delineate the independent and interactive effects of OSA and HIV on the QT variability index (QTVI), a predictor of ventricular arrhythmias and sudden cardiac death. The research will utilize...
This National Heart, Lung, and Blood Institute (NHLBI) funded Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) seeks to develop a novel 3D dynamic MRI (3D-DMRI) scheme to quantify airway collapse in patients with obstructive sleep apnea (OSA). The $426,717 award from August 2024 to May 2029 will be used by The University of Iowa to systematically validate the 3D-DMRI approach and assess its clinical utility for characterizing patterns of airway collapse, both in the...
This Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $644,687 to the University of Missouri System to investigate a critical forebrain-brainstem neural circuit that contributes to the adaptive and maladaptive cardiorespiratory responses to chronic intermittent hypoxia (CIH), a hallmark of obstructive sleep apnea. The research aims to resolve how this "orexin-CRH-NTS" circuit facilitates the peripheral...
This Project Grant award of $133,410 from the National Heart Lung and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate the relationship between sleep quality, sleep apnea, and cardiac aging. The study aims to leverage longitudinal sleep data from the Korean Genome and Epidemiology Study to assess how impaired sleep patterns accelerate cardiovascular disease risk over a 12-year period. The research will focus on...